title: IBD: measuring what counts-safety of IBD medications in pregnancy.
abstract: Uncertainty about the risks of medications for IBD during pregnancy is a challenge for clinicians and patients. a recent prospective cohort study suggests that women under medical care for their disease have few adverse events.
authors.affiliation: Division of Gastroenterology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
authors.forename: Barrett G
authors.initials: BG
authors.lastname: Levesque
authors.forename: Sunanda V
authors.initials: SV
authors.lastname: Kane
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015994:Incidence; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced* / Q000453:epidemiology; D011256:Pregnancy Outcome; D011687:Purines / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011687:Purines